feed,title,long_url,short_url
SeekingAlpha,Agenus stock rises as Q1 revenue soars 121% Y/Y; begins cost-cutting measures,https://seekingalpha.com/news/3835986,
SeekingAlpha,Novavax quarterly results further weigh on vaccine developer down 67% YTD,https://seekingalpha.com/news/3835984,
SeekingAlpha,Neurogenerative disease drug developer Vigil Neuroscience sees stock rally 19%,https://seekingalpha.com/news/3835988,
SeekingAlpha,"Aterian shares erode on earnings miss, cloudy forecast",https://seekingalpha.com/news/3835987,
